Patents by Inventor Anna Gosiewska

Anna Gosiewska has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8277796
    Abstract: Cells derived from postpartum umbilicus and placenta are disclosed. Pharmaceutical compositions, devices and methods for the regeneration or repair of neural tissue using the postpartum-derived cells are also disclosed.
    Type: Grant
    Filed: April 24, 2009
    Date of Patent: October 2, 2012
    Assignee: Advanced Technologies and Regenerative Medicine, LLC
    Inventors: Darin J. Messina, Sanjay Mistry, Alexander M. Harmon, Ian Ross Harris, Anthony J. Kihm, Agnieszka Seyda, Chin-Feng Yi, Anna Gosiewska
  • Patent number: 8039258
    Abstract: The present invention is directed to tissue-engineering scaffolds containing both a microporous scaffold made from a biocompatible material suitable for use in tissue-engineering scaffolds and a nanofiberous, nanoporous hydrogel formed from a self-assembling peptide, where at least a portion of the hydrogel is disposed within the pores of the microporous scaffold, thus providing tissue-engineering scaffolds having average pore diameters in the nanometer range and that provide both mechanical properties suitable for implantation into a body of a mammal and excellent tissue response once implanted in the body.
    Type: Grant
    Filed: September 28, 2004
    Date of Patent: October 18, 2011
    Assignee: Ethicon, Inc.
    Inventors: Ian Ross Harris, Alexander M. Harmon, Laura J. Brown, Anna Gosiewska
  • Patent number: 8034329
    Abstract: Methods for treating a patient having a disease or damage to at least one kidney are provided. The methods comprise administering cells obtained from human umbilical cord tissue, or administering pharmaceutical compositions comprising such cells or prepared from such cells. When administered, the cells promote and support the repair and regeneration of the diseased or damaged kidney tissue in the patient. Pharmaceutical compositions for use in the inventive methods, as well as kits for practicing the methods are also provided.
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: October 11, 2011
    Assignee: Advanced Technologies And Regenerative Medicine, LLC
    Inventors: David C. Colter, Anna Gosiewska
  • Publication number: 20110223205
    Abstract: This invention relates to methods of treating amyotrophic lateral sclerosis. In particular, the invention provides for methods of treating amyotrophic lateral sclerosis by administering umbilical cord tissue-derived cells, an effective amount of a substantially homogenous population of umbilical cord tissue-derived cells or a pharmaceutical composition comprising umbilical cord tissue-derived cells to a patient.
    Type: Application
    Filed: February 14, 2011
    Publication date: September 15, 2011
    Applicant: Advanced Technologies and Regenerative Medicine, LLC
    Inventors: Anna GOSIEWSKA, Alexander M. Harmon, Anthony J. Kihm, Carrie H. Fang, Sridevi Dhanaraj
  • Publication number: 20110091517
    Abstract: A biocompatible tissue repair implant or scaffold device is provided for use in repairing a variety of tissue injuries, particularly injuries to cartilage, ligaments, tendons, and nerves. The repair procedures may be conducted with implants that contain a biological component that assists in healing or tissue repair. The biocompatible tissue repair implants include a biocompatible scaffold and particles of living tissue, such that the tissue and the scaffold become associated. The particles of living tissue contain one or more viable cells that can migrate from the tissue and populate the scaffold.
    Type: Application
    Filed: November 22, 2010
    Publication date: April 21, 2011
    Applicant: DEPUY MITEK, INC.
    Inventors: Francois Binette, Julia Hwang, Sridevi Dhanaraj, Anna Gosiewska
  • Publication number: 20110076769
    Abstract: An isolated mammalian internal mammary artery-derived cell is disclosed. Furthermore, methods of isolating the mammalian internal mammary artery-derived cell are disclosed. The cell is useful in tissue engineering technologies, specifically in vascular tissue engineering.
    Type: Application
    Filed: September 20, 2010
    Publication date: March 31, 2011
    Applicant: Advanced Technologies and Regenerative Medicine, LLC
    Inventors: David C. Colter, Charito Buensuceso, Christian C. Kazanecki, Anna Gosiewska
  • Patent number: 7875272
    Abstract: Cells derived from postpartum tissue such as the umbilical cord and placenta, and methods for their use to regenerate, repair, and improve neural tissue, and to improve behavior and neurological function in stroke patients are disclosed.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: January 25, 2011
    Assignee: Ethicon, Incorporated
    Inventors: Darin J. Messina, Sanjay Mistry, L. S. Klaudyne Hong, Brian C. Kramer, Michael J. Romanko, Anna Gosiewska
  • Publication number: 20100260843
    Abstract: Cells derived from postpartum umbilicus and placenta are disclosed. Pharmaceutical compositions, devices and methods for the regeneration or repair of neural tissue using the postpartum-derived cells are also disclosed.
    Type: Application
    Filed: April 24, 2009
    Publication date: October 14, 2010
    Applicant: Ethicon, Incorporated
    Inventors: Darin J. Messina, Sanjay Mistry, Alexander M. Harmon, Ian Ross Harris, Anthony J. Kihm, Agnieszka Seyda, Chin-Feng Yi, Anna Gosiewska
  • Publication number: 20100247499
    Abstract: Methods for treating Alzheimer's disease, or the symptoms of Alzheimer's disease, are provided. Some embodiments are to methods for treatment comprising administering cells obtained from human umbilical cord tissue, or administering pharmaceutical compositions comprising such cells or prepared from such cells, such as cell derivatives. Some embodiments are to methods for treatment comprising hUTC. Pharmaceutical compositions for use in the inventive methods, as well as kits for practicing the methods are also provided.
    Type: Application
    Filed: March 26, 2010
    Publication date: September 30, 2010
    Applicant: ETHICON, INC.
    Inventors: ANTHONY J. KIHM, ANNA GOSIEWSKA
  • Publication number: 20100215714
    Abstract: Cells derived from postpartum tissue such as the umbilical cord and placenta, and methods for their use to regenerate, repair, and improve neural tissue, and to improve behavior and neurological function in stroke patients are disclosed.
    Type: Application
    Filed: January 29, 2010
    Publication date: August 26, 2010
    Applicant: Ethicon, Incorporated
    Inventors: Darin J. MESSINA, Sanjay K. Mistry, L.S. Klaudyne Hong, Brian C. Kramer, Michael J. Romanko, Anna Gosiewska
  • Publication number: 20100210013
    Abstract: Cells derived from human umbilical cords are disclosed along with methods for their therapeutic use. Isolation techniques, culture methods and detailed characterization of the cells with respect to their cell surface markers, gene expression, and their secretion of trophic factors are described.
    Type: Application
    Filed: February 19, 2009
    Publication date: August 19, 2010
    Applicant: Ethicon, Incorporated
    Inventors: Sanjay Mistry, Anthony J. Kihm, Ian Ross Harris, Alexander M. Harmon, Darin J. Messina, Agnieszka Seyda, Chin-Feng Yi, Anna Gosiewska
  • Publication number: 20100158877
    Abstract: Compositions and methods of using cells derived from umbilical cord tissue to stimulate and support lung tissue angiogenesis, to improve blood flow to lung tissue, to regenerate, repair, and improve lung tissue damaged by lung disease, disorder and/or injury, and to protect lung tissue from damage caused by lung disease, disorder and/or injury in a patient.
    Type: Application
    Filed: December 19, 2009
    Publication date: June 24, 2010
    Applicant: Ethicon, Incorporated
    Inventors: David C. Colter, Anthony J. Kihm, Christine K. Ward, Anna Gosiewska
  • Publication number: 20100158880
    Abstract: Methods, pharmaceutical compositions and kits for regenerating or repairing neural tissue, decreasing apoptosis and improving neurological function following injury are disclosed.
    Type: Application
    Filed: December 19, 2009
    Publication date: June 24, 2010
    Applicant: Ethicon, Incorporated
    Inventors: Agnieszka Seyda, Anna Gosiewska
  • Publication number: 20090275129
    Abstract: Compositions and methods of using tissue engineered blood vessels to repair and regenerate blood vessels of patients with vascular disease are disclosed.
    Type: Application
    Filed: April 30, 2009
    Publication date: November 5, 2009
    Applicant: ETHICON, INC.
    Inventors: Kevin Cooper, Iksoo Chun, David C. Colter, Sridevi Dhanaraj, Anna Gosiewska, Agnieszka Seyda, Carrie H. Fang, Chunlin Yang
  • Patent number: 7604817
    Abstract: A device and method for tissue engineering is disclosed. More particularly this invention relates to a bioabsorbable device and a method of its use which promotes controlled new tissue in-growth into voids or cavities occupied by the device as portions of the device are selectively absorbed within a host thereby minimizing collapse of surrounding, pre-existing host tissue into the engineered site.
    Type: Grant
    Filed: September 3, 2003
    Date of Patent: October 20, 2009
    Assignee: Ethicon Endo-Surgery, Inc.
    Inventors: Chin-Feng Yi, Anna Gosiewska, Susan Roweton
  • Patent number: 7560276
    Abstract: Cells derived from postpartum tissue having the potential to support cells of and/or differentiate to cells of a soft tissue lineage, and methods of preparation and use of those postpartum tissue-derived cells, are provided by the invention. The invention also provides methods for the use of such postpartum-derived cells and products related thereto in therapies for conditions of soft tissue.
    Type: Grant
    Filed: June 25, 2004
    Date of Patent: July 14, 2009
    Assignee: Ethicon, Incorporated
    Inventors: Alexander M. Harmon, Ian Ross Harris, Anthony J. Kihm, Sanjay Mistry, Darin J. Messina, Agnieszka Seyda, Chin-Feng Yi, Anna Gosiewska
  • Publication number: 20090169597
    Abstract: Methods for treating a patient having a disease or condition related to IVD degeneration are provided. The methods comprise administering cells obtained from human umbilical cord tissue, or administering pharmaceutical compositions comprising such cells or prepared from such cells. In some embodiments, administering the cells promotes repair and regeneration of degenerated IVD tissue in the patient. Pharmaceutical compositions for use in the inventive methods, as well as kits for practicing the methods are also provided.
    Type: Application
    Filed: December 17, 2008
    Publication date: July 2, 2009
    Applicant: Ethicon, Incorporated
    Inventors: Laura J. Brown, Anna Gosiewska, Anthony J. Kihm, Brian C. Kramer
  • Publication number: 20090163990
    Abstract: Methods for defatting omentum and processes for preparing an a cellular omentum i.e., devitalized or decellularized omentum, comprising extracellular matrix for implantation into a mammalian system. Also constructs for medical applications comprising decellularized omentum.
    Type: Application
    Filed: December 19, 2007
    Publication date: June 25, 2009
    Inventors: Chunlin Yang, Thoppil Mathew John, Anna Gosiewska, Charito S. Buensuceso, David C. Colter, Agnieszka Seyda, Raymond S. Shissias
  • Publication number: 20090092653
    Abstract: Methods for treating a patient having a disease or damage to at least one kidney are provided. The methods comprise administering cells obtained from human umbilical cord tissue, or administering pharmaceutical compositions comprising such cells or prepared from such cells. When administered, the cells promote and support the repair and regeneration of the diseased or damaged kidney tissue in the patient. Pharmaceutical compositions for use in the inventive methods, as well as kits for practicing the methods are also provided.
    Type: Application
    Filed: October 3, 2008
    Publication date: April 9, 2009
    Applicant: Ethicon, Incorporated
    Inventors: David C. COLTER, Anna Gosiewska
  • Patent number: 7510873
    Abstract: Cells derived from human umbilical cords are disclosed along with methods for their therapeutic use. Isolation techniques, culture methods and detailed characterization of the cells with respect to their cell surface markers, gene expression, and their secretion of trophic factors are described.
    Type: Grant
    Filed: June 25, 2004
    Date of Patent: March 31, 2009
    Assignee: Ethicon, Incorporated
    Inventors: Sanjay Mistry, Anthony J. Kihm, Ian Ross Harris, Alexander M. Harmon, Darin J. Messina, Chin-Feng Yi, Anna Gosiewska